{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:51:34Z","timestamp":1791996694991,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bone.2026.118034","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:50:07Z","timestamp":1785221407000},"page":"118034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Seventeen-year follow-up of hypophosphatasia diagnosed in middle-aged siblings harboring a novel intronic and a rare missense ALPL gene mutation"],"prefix":"10.1016","volume":"212","author":[{"given":"Francesco G.","family":"Conti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Mumm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Lionetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Argento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morena","family":"Pisarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Whyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bone.2026.118034_bb0005","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/archpedi.1948.02030020840003","article-title":"Hypophosphatasia; a new developmental anomaly","volume":"75","author":"Rathbun","year":"1948","journal-title":"Am. J. Dis. Child. (1911)"},{"issue":"4","key":"10.1016\/j.bone.2026.118034_bb0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","article-title":"Hypophosphatasia \u2013 aetiology, nosology, pathogenesis, diagnosis and treatment","volume":"12","author":"Whyte","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"issue":"20","key":"10.1016\/j.bone.2026.118034_bb0015","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.1073\/pnas.85.20.7666","article-title":"A missense mutation in the human liver\/bone\/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia","volume":"85","author":"Weiss","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bone.2026.118034_bb0020","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","article-title":"Alkaline phosphatase and hypophosphatasia","volume":"98","author":"Millan","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2026.118034_bb0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12018-013-9139-0","article-title":"Clinical aspects of hypophosphatasia: an update","volume":"11","author":"Hofmann","year":"2013","journal-title":"Clin. Rev. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2026.118034_bb0030","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","article-title":"Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients","volume":"75","author":"Whyte","year":"2015","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2026.118034_bb0035","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1038\/s41467-023-39833-3","article-title":"The structural pathology for hypophosphatasia caused by malfunctional tissue non-specific alkaline phosphatase","volume":"14","author":"Yu","year":"2023","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bone.2026.118034_bb0040","first-page":"823","article-title":"Periarthritis associated with basic calcium phosphate crystal deposition and low levels of serum alkaline phosphatase \u2013 report of three cases from one family","volume":"15","author":"Caspi","year":"1988","journal-title":"J. Rheumatol."},{"issue":"7","key":"10.1016\/j.bone.2026.118034_bb0045","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/jbmr.2178","article-title":"Clinical and radiographic findings in adults with persistent hypophosphatasemia","volume":"29","author":"McKiernan","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2026.118034_bb0050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13023-022-02393-8","article-title":"Clinical profiles of treated and untreated adults with hypophosphatasia in the global HPP registry","volume":"17","author":"Dahir","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.bone.2026.118034_bb0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11914-025-00929-y","article-title":"Pathophysiology of femoral fractures in hypophosphatasia","volume":"23","author":"Tabegna","year":"2025","journal-title":"Curr. Osteoporos. Rep."},{"issue":"6","key":"10.1016\/j.bone.2026.118034_bb0060","first-page":"2142","article-title":"Hypophosphatasia: levels of bone alkaline phosphatase immunoreactivity in serum reflect disease severity","volume":"81","author":"Whyte","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2026.118034_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115300","article-title":"Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia","volume":"134","author":"Whyte","year":"2020","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2026.118034_bb0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00005792-197909000-00001","article-title":"Adult hypophosphatasia. Clinical, laboratory, and genetic investigation of a large kindred with review of the literature","volume":"58","author":"Whyte","year":"1979","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bone.2026.118034_bb0075","doi-asserted-by":"crossref","unstructured":"S. Dillon, A. Armiger, A. Murgoci, L. Skingle, F.G.A. Tabegna, S. McDonald, S. Mumm, M.P. Whyte, M. Garton, K.E.S. Poole, M.J. Duer, Inorganic pyrophosphate disrupts amorphous hydrated bone mineral interfaces in hypophosphatasia, bioRxiv 2025.11.24.689921.","DOI":"10.1101\/2025.11.24.689921"},{"issue":"5","key":"10.1016\/j.bone.2026.118034_bb0080","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/jbmr.1565","article-title":"\u201cAtypical femoral fractures\u201d during bisphosphonate exposure in adult hypophosphatasia","volume":"27","author":"Sutton","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.118034_bb0085","first-page":"S483","article-title":"Hypophosphatasemia in Duchenne muscular dystrophy [LB-SU0004]","volume":"30","author":"Petryk","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2026.118034_bb0090","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/jcp.47.6.529","article-title":"Age related histomorphometric changes in bone in normal British men and women","volume":"47","author":"Rehman","year":"1994","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bone.2026.118034_bb0095","author":"Alexion Europe SAS"},{"issue":"12","key":"10.1016\/j.bone.2026.118034_bb0100","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s00198-015-3272-1","article-title":"Hypophosphatasia: an overview of the disease and its treatment","volume":"26","author":"Bianchi","year":"2015","journal-title":"Osteoporos. Int."},{"issue":"8","key":"10.1016\/j.bone.2026.118034_bb0105","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziae062","article-title":"Improvement in quality of life after asfotase alfa treatment in adults with pediatric-onset hypophosphatasia: data from 5 patient-reported outcome measures","volume":"8","author":"Dahir","year":"2024","journal-title":"JBMR Plus"},{"issue":"9","key":"10.1016\/j.bone.2026.118034_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10395","article-title":"Physical function and health-related quality of life in adults treated with asfotase alfa for pediatric-onset hypophosphatasia","volume":"4","author":"Genest","year":"2020","journal-title":"JBMR Plus"},{"issue":"1","key":"10.1016\/j.bone.2026.118034_bb0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13023-024-03048-6","article-title":"Effectiveness of asfotase alfa for treatment of adults with hypophosphatasia: results from a global registry","volume":"19","author":"Kishnani","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bone.2026.118034_bb0120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bone.2018.12.011","article-title":"Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia","volume":"121","author":"Kishnani","year":"2019","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bone.2026.118034_bb0125","first-page":"e344","article-title":"Adult-onset hypophosphatasia: before and after treatment with asfotase alfa","volume":"5","author":"Magdaleno","year":"2019","journal-title":"AACE Clin. Case Rep."},{"key":"10.1016\/j.bone.2026.118034_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2023.116856","article-title":"Effects of asfotase alfa in adults with pediatric-onset hypophosphatasia over 24 months of treatment","volume":"175","author":"Seefried","year":"2023","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.bone.2026.118034_bb0135","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s00198-021-06025-y","article-title":"Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa","volume":"32","author":"Seefried","year":"2021","journal-title":"Osteoporos. Int."},{"issue":"3","key":"10.1016\/j.bone.2026.118034_bb0140","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00198-023-06844-1","article-title":"Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults","volume":"35","author":"Khan","year":"2024","journal-title":"Osteoporos. Int."},{"issue":"7","key":"10.1016\/j.bone.2026.118034_bb0145","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2106\/00004623-198668070-00004","article-title":"Management of femoral fractures and pseudofractures in adult hypophosphatasia","volume":"68","author":"Coe","year":"1986","journal-title":"J. Bone Joint Surg. Am."},{"issue":"6","key":"10.1016\/j.bone.2026.118034_bb0150","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1359\/jbmr.081253","article-title":"Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia","volume":"24","author":"Whyte","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2026.118034_bb0155","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00198-020-05612-9","article-title":"Bone mineral density and fracture risk in adult patients with hypophosphatasia","volume":"32","author":"Genest","year":"2021","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.bone.2026.118034_bb0160","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0002-9343(82)90474-0","article-title":"Adult hypophosphatasia with chondrocalcinosis and arthropathy. Variable penetrance of hypophosphatasemia in a large Oklahoma kindred","volume":"72","author":"Whyte","year":"1982","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.bone.2026.118034_bb0165","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jbmr.1752","article-title":"Severe skeletal toxicity from protracted etidronate therapy for generalized arterial calcification of infancy","volume":"28","author":"Otero","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2026.118034_bb0170","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00774-017-0888-6","article-title":"Genetic analysis of adults heterozygous for ALPL mutations","volume":"36","author":"Taillandier","year":"2018","journal-title":"J. Bone Miner. Metab."},{"issue":"1\u20132","key":"10.1016\/j.bone.2026.118034_bb0175","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ymgme.2018.07.006","article-title":"Pyridoxal 5\u2032-phosphate and related metabolites in hypophosphatasia: effects of enzyme replacement therapy","volume":"125","author":"Akiyama","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"7","key":"10.1016\/j.bone.2026.118034_bb0180","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/humu.24010","article-title":"Large-scale in vitro functional testing and novel variant scoring via protein modeling provide insights into alkaline phosphatase activity in hypophosphatasia","volume":"41","author":"Del Angel","year":"2020","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.bone.2026.118034_bb0185","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jbmr\/zjag003","article-title":"Hypophosphatasia: who among us is a carrier?","volume":"41","author":"Whyte","year":"2026","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/j.bone.2026.118034_bb0190","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1001\/archinte.1981.00340130158037","article-title":"Fifty-year follow-up of hypophosphatasia","volume":"141","author":"Weinstein","year":"1981","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bone.2026.118034_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2025.117541","article-title":"Markedly discordant hypophosphatasia in a young girl","volume":"199","author":"Prakash","year":"2025","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.bone.2026.118034_bb0200","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1359\/jbmr.2001.16.9.1724","article-title":"Hypophosphatasia: molecular diagnosis of Rathbun\u2019s original case","volume":"16","author":"Mumm","year":"2001","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2026.118034_bb0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13256-019-2045-4","article-title":"Adult hypophosphatasia with compound heterozygous p.Phe327Leu missense and c.1559delT frameshift mutations in tissue-nonspecific alkaline phosphatase gene: a case report","volume":"13","author":"Fukushima","year":"2019","journal-title":"J Med Case Reports"},{"issue":"9","key":"10.1016\/j.bone.2026.118034_bb0210","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/ccr3.2962","article-title":"Identification of a novel homozygous variant in the alkaline phosphate (ALPL) gene associated with hypophosphatasia","volume":"8","author":"Bisgin","year":"2020","journal-title":"Clin. Case Reports"},{"issue":"1","key":"10.1016\/j.bone.2026.118034_bb0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.20945\/2359-3997000000108","article-title":"A rare mutation in hypophosphatasia: a case report of adult form and review of the literature","volume":"63","author":"Galeano-Valle","year":"2019","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2026.118034_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1138599","article-title":"Impact of muscular symptoms and\/or pain on disease characteristics, disability, and quality of life in adult patients with hypophosphatasia: a cross-sectional analysis from the global HPP registry","volume":"14","author":"Dahir","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bone.2026.118034_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.965476","article-title":"Pain and health-related quality of life in patients with hypophosphatasemia with and without ALPL gene mutations","volume":"13","author":"Santurtun","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bone.2026.118034_bb0230","article-title":"Impact of discontinuing 5 years of enzyme replacement treatment in a cohort of 6 adults with hypophosphatasia: a case series","volume":"17","author":"Rockman-Greenberg","year":"2022","journal-title":"Bone Rep."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226002607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226002607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:41:11Z","timestamp":1791996071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328226002607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":46,"alternative-id":["S8756328226002607"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.118034","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seventeen-year follow-up of hypophosphatasia diagnosed in middle-aged siblings harboring a novel intronic and a rare missense ALPL gene mutation","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.118034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118034"}}